Extended-Spectrum Beta-Lactamase Detection with Different Panels for Automated Susceptibility Testing and with a Chromogenic Medium

被引:26
作者
Faerber, J. [1 ]
Moder, K. -A. [1 ]
Layer, F. [1 ]
Tammer, I. [1 ]
Koenig, W. [1 ]
Koenig, B. [1 ]
机构
[1] Univ Magdeburg, Inst Med Microbiol, D-39120 Magdeburg, Germany
关键词
D O I
10.1128/JCM.00777-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Infections caused by extended-spectrum beta-lactamase (ESBL)- and ampC beta-lactamase-producing gram-negative bacteria complicate therapy and limit treatment options. Several different panels for ESBL detection with automated systems exist. In addition, a chromogenic agar medium is available for ESBL screening. We compared two automated identification and susceptibility testing systems with regard to their effectiveness in detecting ESBL production in Enterobacteriaceae: the BD Phoenix system (BD Diagnostic Systems, Sparks, MD) and the Vitek 2 system (bioMerieux, Marcy l'Etoile, France). We tested 114 strains using the Etest as the standard, various available panels for both automated systems (for BD Phoenix, the NMIC/ID-50 and NMIC/ID-70 GN Combo panels for combined identification and susceptibility testing of gram-negative bacilli, and for Vitek 2, the ID-GNB panel for identification of gram-negative bacilli and the AST-N020, AST-N041, and AST-N062 panels for susceptibility testing), and a chromogenic agar medium (bioMerieux, Marcy l'Etoile, France). PCR for common ESBL gene families (encoding TEM, SHV, OXA, and CTX-M) and for chromosomal or plasmid-mediated ampC beta-lactamase genes was conducted to complete the study design. For the tested specimens overall, the chromID ESBL agar showed the highest sensitivity (95.8%) but the lowest specificity (10.5%) compared to the sensitivity and specificity of the Etest (chosen as reference by the authors) for the detection of ESBL-producing strains. The BD Phoenix system showed sensitivities of 77.1% and 84.2% and specificities of 61.5% and 75.0%, respectively, for the NMIC/ID-50 andNMIC/ID-70 panels. The sensitivity of the Vitek 2 system ranged from 78.8% (AST-N020) to 80.6% (AST-N062) and up to 84.2% (AST-N041). The specificities of the respective panels were 50.0% (AST-N041 and AST-N062) and 55.6% (AST-N020). In conclusion, the sensitivities and specificities of ESBL detection by the different methods differ depending on the microorganisms under study.
引用
收藏
页码:3721 / 3727
页数:7
相关论文
共 29 条
  • [21] Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3
    Poirel, L
    Gniadkowski, M
    Nordmann, P
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (06) : 1031 - 1034
  • [22] Extended-spectrum β-lactamases and clinical outcomes:: Current data
    Ramphal, R
    Ambrose, PG
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 : S164 - S172
  • [23] Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD phoenix extended-spectrum β-lactamase detection method
    Sanguinetti, M
    Posteraro, B
    Spanu, T
    Ciccaglione, D
    Romano, L
    Fiori, B
    Nicoletti, G
    Zanetti, S
    Fadda, G
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (04) : 1463 - 1468
  • [24] Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum β-lactamase production in Enterobacter spp.
    Schwaber, MJ
    Navon-Venezia, S
    Chmelnitsky, I
    Leavitt, A
    Schwartz, D
    Carmeli, Y
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (01) : 241 - 243
  • [25] Management of multidrug-resistant organisms in health care settings, 2006
    Siegel, Jane D.
    Rhinehart, Emily
    Jackson, Marguerite
    Chiarello, Linda
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2007, 35 (10) : S165 - S193
  • [26] Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates
    Stürenburg, E
    Sobottka, I
    Feucht, HH
    Mack, D
    Laufs, R
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 45 (01) : 29 - 34
  • [27] Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum β-lactamases in an Enterobacteriaceae strain collection
    Stürenburg, E
    Sobottka, I
    Noor, D
    Laufs, R
    Mack, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) : 134 - 138
  • [28] Comparison of phoenix and VITEK 2 extended-spectrum-β-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized β-lactamases
    Thomson, Kenneth S.
    Cornish, Nancy E.
    Hong, Seong G.
    Hemrick, Kim
    Herdt, Christian
    Moland, Ellen S.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (08) : 2380 - 2384
  • [29] Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures
    Wiegand, Irith
    Geiss, Heinrich K.
    Mack, Dietrich
    Stuerenburg, Enno
    Seifert, Harald
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (04) : 1167 - 1174